Jingxin Pharmaceuticals is a private enterprise. Jingxin Pharmaceuticals refers to Zhejiang Jingxin Pharmaceuticals Co., Ltd. and its predecessor can be traced back to the joint venture between Xinchang Gum Pill General Factory and Beijing Third Pharmaceutical Factory in 1990. After a number of institutional reforms and shareholding changes, and finally on July 15, 2004, the company was successfully listed on the Shenzhen Stock Exchange, stock code 002020. since the listing, the company has been relying on strong R & D strength and marketing capabilities, and constantly expanding the product line, increase market share.
Business Scope and Products
Jingxin Pharmaceutical's business scope covers a wide range of areas, including APIs, formulations and medical devices. The company has a rich product line, including APIs such as Ciprofloxacin Hydrochloride and Levofloxacin Hydrochloride, as well as a variety of finished dosage forms such as tablets, capsules, and large-capacity injections. These products sell well in international markets such as Southeast Asia, South Asia, Latin America and Europe due to their excellent quality and efficacy.
Jingxin Pharmaceuticals is also committed to the research, development and production of medical devices, and provides professional medical imaging solutions through its wholly-owned subsidiary, Shenzhen Jufeng Display Technology Co, Ltd, further broadening the company's business scope.
R&D Strength and Innovation
Jingxin Pharmaceuticals attaches great importance to research and development and innovation, and owns a number of scientific research institutes, such as post-doctoral scientific research workstations and provincial-level technology centers. The company has established long-term and close technical cooperation relationships with many national pharmaceutical research institutions and famous universities, and continuously cultivates and improves the company's technological innovation ability and scientific research level through independent research and joint development and other ways. The company has owned 8 national key new products and undertaken 9 national torch program projects.
Social Responsibility and CorporateHonors
Social Responsibility: Jingxin Pharmaceuticals actively fulfills its social responsibility while pursuing economic benefits. The company adheres to the mission of "carefully guarding health" and is committed to providing patients with safe and effective medicines and medical devices.
Enterprise honors: China's top 100 enterprises in the pharmaceutical industry, China's top 20 innovative pharmaceuticals, China's Patent Prize Award, China's leading pharmaceutical enterprises in the internationalization of pharmaceutical preparations, the first prize for scientific and technological progress in Zhejiang Province, the first batch of innovative leading enterprises in Zhejiang Province, the national key high-tech enterprises, the National Enterprise Technology Center, the first "China's leading enterprises in the internationalization of pharmaceutical preparations", and the first "China's leading enterprises in the internationalization of pharmaceutical preparations". The first batch of "China's leading enterprises in the internationalization of pharmaceutical preparations", post-doctoral research station, provincial key enterprise research institute, provincial high-tech enterprise R & D center, provincial academician expert workstation, through the U.S. FDA on-site certification, through the German GMP certification, China's top ten leading brands of pharmaceuticals, the national intellectual property rights advantageous enterprises.
Future Expectations
Jingxin Pharmaceuticals will continue to adhere to the business policy of "Strengthening Pharmaceuticals and Developing Medical Devices", and "Carefully Guarding Health" as its mission. With the mission of "carefully guarding health", Jingxin will become a leader in China's psycho-neurological and cardio-vascular fields. By continuously increasing investment in research and development, optimizing product structure, expanding international markets and other measures, Jingxin Pharmaceuticals is expected to achieve more brilliant development in the future.